UnitedHealth hit with widening DOJ criminal investigation into drug pricing, Medicare billing, and physician payments in sweeping federal crackdown

UnitedHealth Group is not just under review. It is under federal criminal investigation, and the scope keeps growing. What started as questions over Medicare Advantage billing has now expanded into OptumRx’s prescription management services and the way the company reimburses physicians.

“The investigation is looking at how OptumRx negotiates drug prices and reimburses pharmacies,”
reported Bloomberg,
noting that the system touches millions of Americans and billions of federal dollars.

Yahoo Finance confirmed the probe is broader than initially disclosed, reaching physician payment models and internal coding practices. These are not side issues. They go to the core of how the country’s largest insurer makes money from both doctors and patients.

UnitedHealth, in its own SEC filing, admitted the existence of civil and criminal investigations while insisting it has “full confidence” in its practices. But confidence is not compliance. The Hill highlighted how the company is now conducting an internal review of its risk coding and managed care structures.

“This is deeply concerning because of the scope of the company’s reach,”
said one industry analyst, warning that flaws inside UnitedHealth ripple across the entire health system.

This is no routine billing audit. It is a federal dissection of how the nation’s largest health insurer manages care, costs, and compliance. The DOJ is pulling threads, and what unravels may reshape how Americans pay for their medicine.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *